Page 531 - Si Reporter

Pvt banks, IT drag Sensex 230pts down, Nifty below 18,350; Paytm tanks 10%

CLOSING BELL: Among the Sensex 30 shares, Titan, M&M, Maruti, HDFC and Bajaj Finserv were the major per centage losers.

L&T Infotech, Mindtree extend fall ahead of merger, down up to 7% in 3 days

The board of directors of LTI and Mindtree fixed November 24, 2022 as the 'Record Date' for the purpose of determining eligibility of Mindtree shareholders to get shares of the amalgamated company.

Sensex ends choppy day 108 pts up; Adani group stocks tumble, defence rally

CLOSING BELL: The S&P BSE Sensex is now just 265 points shy from its all-time 62,245 registered on October 19, 2021.

HAL gets LoI for 9 helicopters from Indian Coast Guard; stock rallies 7%

So far in calendar year 2022, the stock price of HAL has zoomed 123 per cent as compared to a 4.8 per cent rise in the S&P BSE Sensex

Kirloskar Oil Engines soars 11%, hits over 4-year high on strong Q2 results

In the past three months, the market price of KOEL has appreciated by 86 per cent as compared to a 3.6 per cent rise in the S&P BSE Sensex

Stock of this shipping company has zoomed nearly 250% in last four months

On Monday, the board of KMEW approved the allotment of 565,000 equity shares at an issue price of Rs 700 per equity share on a preferential basis to investor Ashish Kacholia and others.

Sugar stocks in focus; Balrampur Chini gains 3% as share buyback commences

The board of directors of Balrampur Chini on November 9 had approved Rs 145.44 crore share buyback at Rs 360 per share through the open market route.

Nykaa extends fall on listing of bonus shares; stock slips 17% in two days

At 09:15 am, around 30.62 million shares changed hands on the BSE, the exchange data showed

This non banking finance company's stock has zoomed over 100% in 5 months

Shares of Ujjivan Financial Services (UFSL) hit a fresh 52-week high of Rs 295.35 as they surged 6 per cent on the BSE in Tuesday's intra-day trade

Sensex jumps 249 pts on late buying, Nifty tops 18,400; Airtel, ICICI lead

CLOSING BELL: A late rally in the market, helped the benchmark indices end the rather lacklustre day with notable gains. Debutant Fusion MicroFinance ended at a 12 per cent discount to issue price.

Globus Spirits slumps 13% on weak Q2 results; stock tanks 59% in 10 months

Its Q2 earnings before interest, taxes, depreciation, and amortization (ebitda) was down 47.4 per cent YoY and 33.2 percent QoQ at Rs 47 crore

Apollo Tyres surges 6% post Sept quarter result; stock nears record high

The company reported a double digit growth in revenue, and ebitda in the September quarter despite challenging environment

Rail Vikas Nigam zooms 62% in 16 trading sessions on strong order inflows

In the past three months, the stock price of RVNL has zoomed 90 per cent, as compared to a 3 per cent gain on the Sensex.

ONGC up 3%, hits 4-month high post Q2 nos; board okays 35% interim dividend

Current trend in global oil & gas prices augurs well for ONGC, according to analysts.

Sensex falls 171 pts, Nifty holds 18,300; Dr.Reddy's down 4%, LIC jumps 6%

CLOSING BELL: The key benchmark indices gyrated in a narrow trading band on Monday, before settling with losses as FMCG stocks slipped.

Ambuja Cements rallies 5%, hits all-time high in a range-bound market

With aggressive expansion strategy, and focus on cost efficiencies, analysts at ICICI Securities expect healthy revenue growth in CY21-23E despite high base

Hospital stocks gain in tepid mkt; Krishna Institute, Fortis rise up to 11%

Apollo Hospitals Enterprise, and Narayana Hrudayalaya advanced 3 per cent each in the intra-day trade

Stock of this auto ancillary company has doubled in just 5 months

Shares of Fiem Industries hit a new high at Rs 2,024.95, and have rallied 22% in the past two days after the company reported 54% YoY jump in its consolidated net profit.

Cochin Shipyard soars 13% in 2 days on healthy order book

ICICI Securities remains positive on CSL led by strong earnings visibility considering healthy order backlog, expected pick-up in execution, and strong opportunities in ship-building segment

Aurobindo Pharma slips 7%, hits over 2-year low on weak Q2 results

The company said the second quarter performance was subdued mainly due to the macro-environment factors and higher competitive intensity for some products in the US